Overexpression of PACAP in transgenic mouse pancreatic β-cells enhances insulin secretion and ameliorates streptozotocin-induced diabetes

Diabetes

Volumn 52, Issue 5, 2003, Pages 1155-1162

  Yamamoto, Kyohei ^a   Hashimoto, Hitoshi ^a   Tomimoto, Shuhei ^a   Shintani, Norihito ^a   Miyazaki, Jun ichi ^b   Tashiro, Fumi ^b   Aihara, Hiroyuki ^b   Nammo, Takao ^a   Li, Ming ^a   Yamagata, Kazuya ^a   Miyagawa, Jun ichiro ^a   Matsuzawa, Yuji ^a   Kawabata, Yuki ^a   Fukuyama, Yuji ^a   Koga, Kazumi ^a   Mori, Wakaba ^a   Tanaka, Kazuhiro ^a   Matsuda, Toshio ^a   Baba, Akemichi ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; MORPHOMETRICS; MOUSE; NICK END LABELING; NONHUMAN; NORTHERN BLOTTING; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; INSULIN; ISLETS OF LANGERHANS; KINETICS; MICE; MICE, TRANSGENIC; NEUROPEPTIDES; ORGAN SPECIFICITY; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TIME FACTORS;

EID: 12444252950     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.5.1155     Document Type: Article

References (46)

1. Arimura A: Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48:301-331, 1998
2. Filipsson K, Kvist Reimer M, Ahren B: The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function. Diabetes 50:1959-1969, 2001
3. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H: Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52:269-324, 2000
4. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, Waschek JA: International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50:265-270, 1998
5. Hashimoto H, Ishihara T, Shigemoto R, Mori K, Nagata S: Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide. Neuron 11:333-342, 1993
6. Fridolf T, Sundler F, Ahren B: Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse. Cell Tissue Res 269:275-279, 1992
7. Yada T, Sakurada M, Ihida K, Nakata M, Murata F, Arimura A, Kikuchi M: Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet β-cells. J Biol Chem 269:1290-1293, 1994
8. Yada T, Sakurada M, Ishihara H, Nakata M, Shioda S, Yaekura K, Hamakawa N, Yanagida K, Kikuchi M, Oka Y: Pituitary adenylate cyclase-activating polypeptide (PACAP) is an islet substance serving as an intra-islet amplifier of glucose-induced insulin secretion in rats. J Physiol 505:319-328, 1997
9. Bertrand G, Puech R, Maisonnasse Y, Bockaert J, Loubatieres Mariani MM: Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat. Br J Pharmacol 117:764-770, 1996
10. Filipsson K, Sundler F, Hannibal J, Ahren B: PACAP and PACAP receptors in insulin producing tissues: localization and effects. Regul Pept 74:167-175, 1998
11. Filipsson K, Tornoe K, Holst J, Ahren B: Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans. J Clin Endocrinol Metab 82:3093-3098, 1997
12. Kato I, Suzuki Y, Akabane A, Yonekura H, Tanaka O, Kondo H, Takasawa S, Yoshimoto T, Okamoto H: Transgenic mice overexpressing human vasoactive intestinal peptide (VIP) gene in pancreatic β-cells. Evidence for improved glucose tolerance and enhanced insulin secretion by VIP and PHM-27 in vivo. J Biol Chem 269:21223-21228, 1994
13. Hashimoto H, Hagihara N, Koga K, Yamamoto K, Shintani N, Tomimoto S, Mori W, Koyama Y, Matsuda T, Baba A: Synergistic induction of pituitary adenylate cyclase-activating polypeptide (PACAP) gene expression by nerve growth factor and PACAP in PC12 cells. J Neurochem 74:501-507, 2000
14. Sakai Y, Hashimoto H, Shintani N, Tomimoto S, Tanaka K, Ichibori A, Hirose M, Baba A: Involvement of p38 MAP kinase pathway in the synergistic activation of PACAP mRNA expression by NGF and PACAP in PC12h cells. Biochem Biophys Res Commun 285:656-661, 2001
15. 2+ elevation but not cyclic AMP in PACAP-induced p38 MAP kinase activation in PC12 cells. Regul Pept 109:149-153, 2002
16. Schafer H, Zheng J, Gundlach F, Gunther R, Siegel EG, Folsch UR, Schmidt WE: Pituitary adenylate-cyclase-activating polypeptide stimulates protooncogene expression and activates the AP-1 (c-Fos/c-Jun) transcription factor in AR4-2J pancreatic carcinoma cells. Eur J Biochem 242:467-476, 1996
17. Hashimoto H, Yamamoto K, Hagihara N, Ogawa N, Nishino A, Aino H, Nogi H, Imanishi K, Matsuda T, Baba A: cDNA cloning of a mouse pituitary adenylate cyclase-activating polypeptide receptor. Biochim Biophys Acta 1281:129-133, 1996
18. Aino H, Hashimoto H, Ogawa N, Nishino A, Yamamoto K, Nogi H, Nagata S, Baba A: Structure of the gene encoding the mouse pituitary adenylate cyclase-activating polypeptide receptor. Gene 164:301-304, 1995
19. 1) receptor. Genomics 58:90-93, 1999
20. Yamamoto K, Hashimoto H, Hagihara N, Nishino A, Fujita T, Matsuda T, Baba A: Cloning and characterization of the mouse pituitary adenylate cyclase-activating polypeptide (PACAP) gene. Gene 211:63-69, 1998
21. Hashimoto H, Nogi H, Mori K, Ohishi H, Shigemoto R, Yamamoto K, Matsuda T, Mizuno N, Nagata S, Baba A: Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study. J Comp Neurol 371:567-577, 1996
22. Nogi H, Hashimoto H, Fujita T, Hagihara N, Matsuda T, Baba A: Pituitary adenylate cyclase-activating polypeptide (PACAP) receptor mRNA in the rat adrenal gland: localization by in situ hybridization and identification of splice variants. Jpn J Pharmacol 75:203-207, 1997
23. Nogi H, Hashimoto H, Hagihara N, Shimada S, Yamamoto K, Matsuda T, Tohyama M, Baba A: Distribution of mRNAs for pituitary adenylate cyclase-activating polypeptide (PACAP), PACAP receptor, vasoactive intestinal polypeptide (VIP), and VIP receptors in the rat superior cervical ganglion. Neurosci Lett 227:37-40, 1997
24. 1) receptor expression by targeted deletion of the signal peptide. J Neurochem 75:1810-1817, 2000
25. Jamen F, Persson K, Bertrand G, Rodriguez Henche N, Puech R, Bockaert J, Ahren B, Brabet P: PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance. J Clin Invest 105:1307-1315, 2000
26. Hashimoto H, Shintani N, Tanaka K, Mori W, Hirose M, Matsuda T, Sakaue M, Miyazaki J, Niwa H, Tashiro F, Yamamoto K, Koga K, Tomimoto S, Kunugi A, Suetake S, Baba A: Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci U S A 98:13355-13360, 2001
27. Gray SL, Cummings KJ, Jirik FR, Sherwood NM: Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol 15:1739-1747, 2001
28. Wei Y, Mojsov S: Tissue specific expression of different human receptor types for pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide: implications for their role in human physiology. J Neuroendocrinol 8:811-817, 1996
29. Ishihara H, Tashiro F, Ikuta K, Asano T, Katagiri H, Inukai K, Kikuchi M, Yazaki Y, Oka Y, Miyazaki J: Inhibition of pancreatic β-cell glucokinase by antisense RNA expression in transgenic mice: mouse strain-dependent alteration of glucose tolerance. FEBS Lett 371:329-332, 1995
30. Yagui K, Yamaguchi T, Kanatsuka A, Shimada F, Huang CI, Tokuyama Y, Ohsawa H, Yamamura K, Miyazaki J, Mikata A, Yoshida S, Makino H: Formation of islet amyloid fibrils in β-secretory granules of transgenic mice expressing human islet amyloid polypeptide/amylin. Eur J Endocrinol 132:487-496, 1995
31. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
32. Vasavada RC, Cavaliere C, D'Ercole AJ, Dann P, Burtis WJ, Madlener AL, Zawalich K, Zawalich W, Philbrick W, Stewart AF: Overexpression of parathyroid hormone-related protein in the pancreatic islets of transgenic mice causes islet hyperplasia, hyperinsulinemia, and hypoglycemia. J Biol Chem 271:1200-1208, 1996
33. Yokota C, Kawai K, Ohashi S, Watanabe Y, Suzuki S, Yamashita K: Stimulatory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on insulin and glucagon release from the isolated perfused rat pancreas. Acta Endocrinol 129:473-479, 1993
34. Tamakawa H, Miyata A, Satoh K, Miyake Y, Matsuo H, Arimura A, Kangawa K: The augmentation of pituitary adenylate cyclase-activating polypeptide (PACAP) in streptozotocin-induced diabetic rats. Peptides 19:1497-1502, 1998
35. Sekiguchi Y, Kasai K, Hasegawa K, Suzuki Y, Shimoda S: Glycogenolytic activity of pituitary adenylate cyclase activating polypeptide (PACAP) in vivo and in vitro. Life Sci 55:1219-1228, 1994
36. Yokota C, Kawai K, Ohashi S, Watanabe Y, Yamashita K: PACAP stimulates glucose output from the perfused rat liver. Peptides 16:55-60, 1995
37. Tams JW, Johnsen AH, Fahrenkrug J: Identification of pituitary adenylate cyclase-activating polypeptide 1-38-binding factor in human plasma, as ceruloplasmin. Biochem J 341:271-276, 1999
38. 2+ toxicity in islet β-cells and its prevention by PACAP. Peptides 23:135-142, 2002
39. ATP channel. Proc Natl Acad Sci U S A 94:11969-11973, 1997
40. Yada T, Sakurada M, Filipsson K, Kikuchi M, Ahren B: Intraperitoneal PACAP administration decreases blood glucose in GK rats, and in normal and high fat diet mice. Ann N Y Acad Sci 921:259-263, 2000
41. Hosoya M, Kimura C, Ogi K, Ohkubo S, Miyamoto Y, Kugoh H, Shimizu M, Onda H, Oshimura M, Arimura A, Fujino M: Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. Biochim Biophys Acta 1129:199-206, 1992
42. Parker A, Meyer J, Lewitzky S, Rennich JS, Chan G, Thomas JD, Orho-Melander M, Lehtovirta M, Forsblom C, Hyrkko A, Carlsson M, Lindgren C, Groop LC: A gene conferring susceptibility to type 2 diabetes in conjunction with obesity is located on chromosome 18p11. Diabetes 50:675-680, 2001
43. Shima K, Hirota M, Ohboshi C: Effect of glucagon-like peptide-1 on insulin secretion. Regul Pept 22:245-252, 1988
44. Leech CA, Holz GG, Habener JF: Signal transduction of PACAP and GLP-1 in pancreatic β-cells. Ann N Y Acad Sci 805:81-93, 1996
45. Zhou J, Wang X, Pineyro MA, Egan JM: Glucagon-hke peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulinproducing cells. Diabetes 48:2358-2366, 1999
46. Xu G, Stoffers DA, Habener JF, Bonner Weir S: Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270-2276, 1999